HALOZYME THERAPEUTICS INC

Ticker: HALO CUSIP: 40637H109 Class: EQTY

BERNZOTT CAPITAL ADVISORS's Holding History (CIK: 0001260468)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 67,794 Value ($000) $4,563 Avg Close $67.27 Range $61.23 - $76.30
Q3 2025
Shares 69,252 Value ($000) $5,079 Avg Close $66.43 Range $51.78 - $79.50
Q2 2025
Shares 70,403 Value ($000) $3,662 Avg Close $56.90 Range $47.50 - $70.51
Q1 2025
Shares 101,760 Value ($000) $6,493 Avg Close $58.09 Range $47.52 - $66.00
Q4 2024
Shares 93,985 Value ($000) $4,493 Avg Close $51.28 Range $42.01 - $62.13
Q2 2024
Shares 187,249 Value ($000) $9,804 Avg Close $43.86 Range $37.73 - $53.00
Q1 2024
Shares 209,804 Value ($000) $8,535 Avg Close $37.49 Range $33.15 - $42.64
Q4 2023
Shares 124,979 Value ($000) $4,619 Avg Close $37.66 Range $32.83 - $42.82
Q3 2023
Shares 171,808 Value ($000) $6,563 Avg Close $40.96 Range $35.71 - $45.00
Q2 2023
Shares 304,009 Value ($000) $10,966 Avg Close $34.12 Range $29.85 - $38.80
Q1 2023
Shares 321,415 Value ($000) $12,275 Avg Close $46.91 Range $32.83 - $57.00
Q4 2022
Shares 444,728 Value ($000) $25,305 Avg Close $51.20 Range $39.17 - $59.46
Q3 2022
Shares 455,583 Value ($000) $18,014 Avg Close $44.20 Range $38.03 - $52.98
Q2 2022
Shares 372,818 Value ($000) $16,404 Avg Close $43.25 Range $36.95 - $48.58
Q1 2022
Shares 256,185 Value ($000) $10,217 Avg Close $35.62 Range $31.36 - $42.33